These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 23262166)

  • 21. Recent advances in liposomal dry powder formulations: preparation and evaluation.
    Misra A; Jinturkar K; Patel D; Lalani J; Chougule M
    Expert Opin Drug Deliv; 2009 Jan; 6(1):71-89. PubMed ID: 19236209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
    Padamwar MN; Pokharkar VB
    Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nebulization of ultradeformable liposomes: the influence of aerosolization mechanism and formulation excipients.
    Elhissi AM; Giebultowicz J; Stec AA; Wroczynski P; Ahmed W; Alhnan MA; Phoenix D; Taylor KM
    Int J Pharm; 2012 Oct; 436(1-2):519-26. PubMed ID: 22796173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suitability of liposomal carriers for systemic delivery of risedronate using the pulmonary route.
    Nasr M; Taha I; Hathout RM
    Drug Deliv; 2013 Nov; 20(8):311-8. PubMed ID: 24079347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of different vitamin E carriers intended for pulmonary drug delivery.
    Laouini A; Andrieu V; Vecellio L; Fessi H; Charcosset C
    Int J Pharm; 2014 Aug; 471(1-2):385-90. PubMed ID: 24939617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery.
    Souto EB; Wissing SA; Barbosa CM; Müller RH
    Int J Pharm; 2004 Jun; 278(1):71-7. PubMed ID: 15158950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liposomal Aerosols of Nitric Oxide (NO) Donor as a Long-Acting Substitute for the Ultra-Short-Acting Inhaled NO in the Treatment of PAH.
    Nahar K; Rashid J; Absar S; Al-Saikhan FI; Ahsan F
    Pharm Res; 2016 Jul; 33(7):1696-710. PubMed ID: 27048347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Factors of elimination of liposome-encapsulated drug model substances after intravenous administration].
    Kibat P; Stricker H
    Arzneimittelforschung; 1988 Oct; 38(10):1472-8. PubMed ID: 3196388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
    Khan MA; Owais M
    J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary absorption of aerosolized fluorescent markers in the isolated rabbit lung.
    Lahnstein K; Schmehl T; Rüsch U; Rieger M; Seeger W; Gessler T
    Int J Pharm; 2008 Mar; 351(1-2):158-64. PubMed ID: 17980981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liposomal formulations for inhalation.
    Cipolla D; Gonda I; Chan HK
    Ther Deliv; 2013 Aug; 4(8):1047-72. PubMed ID: 23919478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liposil, a promising composite material for drug storage and release.
    Bégu S; Aubert Pouëssel A; Lerner DA; Tourné-Péteilh C; Devoisselle JM
    J Control Release; 2007 Mar; 118(1):1-6. PubMed ID: 17250924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro evaluation of nebulization properties, antimicrobial activity, and regional airway surface liquid concentration of liposomal polymyxin B sulfate.
    Desai TR; Tyrrell GJ; Ng T; Finlay WH
    Pharm Res; 2003 Mar; 20(3):442-7. PubMed ID: 12669966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chitosan hydrogels containing liposomes and cubosomes as particulate sustained release vaccine delivery systems.
    Gordon S; Young K; Wilson R; Rizwan S; Kemp R; Rades T; Hook S
    J Liposome Res; 2012 Sep; 22(3):193-204. PubMed ID: 22188610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of temoporfin-loaded liposome formulations: correlation of liposome and temoporfin blood concentration.
    Decker C; Schubert H; May S; Fahr A
    J Control Release; 2013 Mar; 166(3):277-85. PubMed ID: 23313962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
    Bhatia A; Kumar R; Katare OP
    J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro kinetics of drug release and pulmonary retention of microencapsulated antibiotic in liposomal formulations in relation to the lipid composition.
    Beaulac C; Clement-Major S; Hawari J; Lagace J
    J Microencapsul; 1997; 14(3):335-48. PubMed ID: 9147283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chimeric advanced drug delivery nano systems (chi-aDDnSs) for shikonin combining dendritic and liposomal technology.
    Kontogiannopoulos KN; Assimopoulou AN; Hatziantoniou S; Karatasos K; Demetzos C; Papageorgiou VP
    Int J Pharm; 2012 Jan; 422(1-2):381-9. PubMed ID: 21979251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and characterization of cefditoren pivoxil-loaded liposomes for controlled in vitro and in vivo drug release.
    Venugopalarao G; Lakshmipathy R; Sarada NC
    Int J Nanomedicine; 2015; 10 Suppl 1(Suppl 1):149-57. PubMed ID: 26491316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and characterization of minoxidil-loaded liposomal system for delivery to pilosebaceous units.
    Jain B; Singh B; Katare OP; Vyas SP
    J Liposome Res; 2010 Jun; 20(2):105-14. PubMed ID: 19698000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.